Institutions do more than regulate science. They determine which science becomes possible.

After years of watching institutions dismiss the research they could not classify, molecular biologist Michael J. Dunston is offered something almost unimaginable: a laboratory, substantial resources, and permission to pursue his work without obstruction. The offer comes from Julian Mercer, the perceptive founder of Helixion, a rapidly expanding biotechnology company.

As Michael’s research gains credibility, a federal preparedness initiative begins transforming Helixion. New departments appear. Funding expands. Safeguards multiply. Scientists, executives, regulators, and government officials make careful, defensible decisions to pursue a shared objective: preparing for a biological threat before it exists.

Then a mysterious pathogen emerges in Paris. As infections spread and governments struggle to respond, Helixion discovers that its existing research may provide the fastest path to an effective vaccine. Institutional barriers disappear, development accelerates, and the company becomes uniquely positioned to save millions of lives. It also becomes extraordinarily valuable.

Blending scientific suspense, institutional satire, and unsettling plausibility, Bioweaponized Capitalism, explores what happens when human judgment is distributed across systems designed to manage risk, reward innovation, and protect themselves.